Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Climb Bio Inc (CLYM) Institutional Ownership & Insider Trading

109 institutions reported holding Climb Bio Inc shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 9 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CLYMClimb Bio IncFollow CLYM — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
585.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

109 institutions held 98.1% of the shares. Across filers that reported both quarters, shares held changed +74.8%.

Increased+32New+50Decreased-18Closed-19

Largest moves, shares (millions)

FMR+6.8MUBS Group AG+3.3MAdage Capital Partners Gp+2.5MMpm Bioimpact-2.6MKynam Capital Management-1.0MMarshall Wace-0.8M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24+0.5Dec 24-1.3Mar 25-1.8Jun 25-5.3Sep 25-12.9Dec 25+1.6Mar 26+24.1Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2610956+74.8%32501819
Mar 267932+5.3%2122229
Dec 256431-29.6%19141815
Sep 256745-10.6%11103412
Jun 256850-3.5%16182223
Mar 257552-2.5%2291914
Dec 247956+1.0%28181014
Sep 247155—————

Climb Bio Inc — questions

Who owns Climb Bio Inc stock?
109 institutions reported Climb Bio Inc shares in 13F filings for the quarter ended 2026-06-30. The largest: RA CAPITAL MANAGEMENT, L.P. (19.7%), FMR LLC (11.8%), UBS Group AG (5.9%).
Are Climb Bio Inc insiders buying or selling?
9 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Climb Bio Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.